Investing Ideas
/
Australian Pharmaceuticals & Biotech High Insider Buying

Australian Pharmaceuticals & Biotech High Insider Buying

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

0 new

Stocks with high levels of insider buying the past 3 months and good analyst coverage.

12 companies

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
MSB Mesoblast	AU$2.66	-5.0%	817.2%	AU$3.4b	AU$2.69	PS365.6x	E54.9%	n/a
OCC Orthocell	AU$1.41	-10.2%	235.7%	AU$338.3m	n/a	PS63.7x	n/a	n/a
TRJ Trajan Group Holdings	AU$0.80	-3.6%	-34.4%	AU$121.9m	AU$1.45	PS0.8x	E98.8%	n/a
EZZ EZZ Life Science Holdings	AU$1.99	-1.7%	305.1%	AU$93.6m	AU$5.45	PE13.4x	E17.9%	1.5%
VFY Vitrafy Life Sciences	AU$1.45	0.2%	n/a	AU$92.4m	AU$2.15	PB2.7x	E60.9%	n/a
CYP Cynata Therapeutics	AU$0.24	-2.0%	22.5%	AU$55.2m	AU$0.83	PS23.8x	E72.9%	n/a
ATX Amplia Therapeutics	AU$0.082	-2.4%	9.3%	AU$31.8m	n/a	PS9.3x	n/a	n/a
OSL OncoSil Medical	AU$0.006	0%	-33.3%	AU$27.6m	n/a	PS17.6x	n/a	n/a
CAN Cann Group	AU$0.03	0%	-56.5%	AU$16.1m	n/a	PS0.9x	n/a	n/a
PER Percheron Therapeutics	AU$0.013	62.5%	-81.7%	AU$14.1m	n/a	PS7.4x	n/a	n/a
CHM Chimeric Therapeutics	AU$0.008	23.1%	-69.2%	AU$12.6m	n/a	PS1.7x	n/a	n/a
ACR Acrux	AU$0.03	-3.2%	-48.3%	AU$12.1m	AU$0.11	PS2.4x	E91.8%	0%

Page 1 of 1